LONDON (AP) _ A Scandinavian study confirms the effectiveness of
using both radiation and hormone-blocking drugs in treating
advanced prostate cancer.
Researchers say the study found that men who got both had just half the death rate of men who received only one of the treatments. The combination has been the standard in the U.S. since the 1990s, but has been avoided by many European doctors for fear it's too harsh.
Using both radiation and drugs does have its costs. After five years, patients reported higher rates of side effects including fatigue, insomnia, and sexual problems.
The study was published online by the British medical journal, Lancet. It was paid for by various Scandinavian cancer groups, a university, and the makers of the drugs used in the study.